University of Rostock
Human cord blood cells stimulate angiogenesis in myocardial infarction models
Published in Women's Health Law Weekly, June 5th, 2005
According to a study from Germany, "we tested the hypothesis that intravenously administered human umbilical cord blood (hUCB) cells contribute to repair processes following myocardial infarction."
"hUCB mononuclear cells containing 0.11% to 1.1% CD34+ cells were injected in the tail vein of non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice that had myocardial infarction (MI+) or had not (MI-) previously undergone ligation of the left anterior coronary artery (LAD). Homing to bone marrow and solid organs was determined by polymerase chain reaction (PCR)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Amer. College of Obstetricians and Gynecologists
ACOG updates guide to pregnancy - Christian Medical College & Hospital, Tamil Nadu
Penicillium marneffei diagnosed in HIV-infected patients in south India - Osaka Bioscience Institute
AMAP1 expression provides targets to inhibit breast cancer invasive activities - Sahlgrenska Academy, Gothenburg
Acupuncture, stabilizing exercises complement usual treatment in pregnant women - Adeza
Women's health product maker reports net income doubled in 1Q - Adiana, Inc.
Treatment phase of transcervical sterilization trial is completed - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
